Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST
Strong revenue growth fails to shield India Inc margins in March quarterCorporate India's March 2026 quarter results showed a mixed performance. While revenues grew strongly, input cost inflation and a weaker ru...
26 May, 2026, 06.17 AM IST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
20 May, 2026, 12.05 PM IST
Ahead of Market: 10 things that will decide stock market action on FridayBSE Sensex and Nifty 50 extended gains for a second session, led by banking, metal and pharma stocks despite IT weakness. Analysts flagged ...
14 May, 2026, 10.31 PM IST
NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...
14 May, 2026, 12.05 PM IST
Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
14 May, 2026, 11.04 AM IST
Cipla Q4 net profit slumps 55% YoY to Rs 555 crore, full-year PAT down 26%Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the f...
14 May, 2026, 12.47 AM IST
Cipla Q4 profit drops 55% to Rs 555 crore; board recommends Rs 13 dividendCipla's fourth-quarter net profit saw a significant drop of 55 percent year-on-year. For the full financial year, the company's profit also...
13 May, 2026, 04.19 PM IST
Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
13 May, 2026, 01.18 PM IST
Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....
13 May, 2026, 06.46 AM IST
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
04 May, 2026, 06.00 AM IST
Cipla shares slide 5% after drug major's Q3 net profit drops 57% YoYCipla shares dropped 5% after reporting a 57% year-on-year decline in net profit to Rs 676 crore, impacted by a fall in gRevlimid sales. Re...
23 Jan, 2026, 03.22 PM IST
Cipla Q2 Results: Net profit grows 4% YoY to Rs 1,351 crore; revenue rises 8%Cipla Q2 Results: Cipla reported a 4% YoY growth in net profit to Rs 1,351 crore and an 8% rise in revenue to Rs 7,589 crore. The company s...
30 Oct, 2025, 01.41 PM IST
Buy Cipla, target price Rs 1320: Axis SecuritiesCipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 91652.55 Crore) operating in Pharmaceuticals s...
20 Oct, 2022, 11.12 AM IST
Buy Cipla, target price Rs 1145: Axis SecuritiesCipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 85350.61 Crore) operating in Pharmaceuticals s...
20 Sep, 2022, 11.01 AM IST
- Brokers’ Call: Espirito puts a buy on Cipla
Espirito Santo Securities has given a ‘Buy’ rating on Cipla with a fair value of Rs 440.
08 Mar, 2013, 06.20 AM IST